Stock Earnings

Question 1

What are Abbott Laboratories's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Abbott Laboratories has a total asset of $81,414, Net profit of $13,402

Question 2

What are the key financial ratios for ABT?

Accepted Answer

Abbott Laboratories's Current ratio is 2.41, has a Net margin is 31.94, sales per share of $23.99.

Question 3

How is Abbott Laboratories's revenue broken down by segment or geography?

Accepted Answer

Abbott Laboratories largest revenue segment is Established Pharmaceutical Products, at a revenue of 5,194,000,000 in the most earnings release.For geography, United States is the primary market for Abbott Laboratories, at a revenue of 16,323,000,000.

Question 4

Is Abbott Laboratories profitable?

Accepted Answer

yes, according to the latest financial statements, Abbott Laboratories has a net profit of $13,402

Question 5

Does Abbott Laboratories have any liabilities?

Accepted Answer

yes, Abbott Laboratories has liability of 33,750

Question 6

How many outstanding shares for Abbott Laboratories?

Accepted Answer

Abbott Laboratories has a total outstanding shares of 1,731.69

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	43,843	41,950	40,109	43,653	43,075	34,608
Revenue Growth (YoY)	6%	5%	-8%	1%	24%	8%
Cost of Revenue	19,209	18,644	17,919	19,083	18,490	14,967
Gross Profit	24,634	23,306	22,190	24,570	24,585	19,641
Selling, General & Admin	12,021	11,651	10,883	11,109	11,217	9,676
Research & Development	2,867	2,784	2,619	2,741	2,733	2,403
Operating Expenses	16,613	16,313	15,468	15,863	15,997	14,211
Other Non Operating Income (Expenses)	602	558	518	366	277	-12
Pretax Income	8,138	7,013	6,664	8,306	8,211	4,968
Income Tax Expense	-5,839	-6,389	941	1,373	1,140	471
Net Income	13,977	13,402	5,723	6,933	7,071	4,495
Net Income Growth	142%	134%	-17%	-2%	56.99%	22%
Shares Outstanding (Diluted)	1,749	1,748	1,749	1,764	1,789	1,786
Shares Change (YoY)	0%	0%	-1%	-1%	0%	0%
EPS (Diluted)	8.01	7.67	3.27	3.93	3.95	2.52
EPS Growth	143%	135%	-17%	-1%	56.99%	22%
Free Cash Flow	6,917	6,351	5,059	7,804	8,648	5,724
Free Cash Flow Per Share	3.95	3.63	2.89	4.42	4.83	3.2
Gross Margin	56.18%	55.55%	55.32%	56.28%	57.07%	56.75%
Operating Margin	18.29%	16.66%	16.75%	19.94%	19.93%	15.69%
Profit Margin	31.87%	31.94%	14.26%	15.88%	16.41%	12.98%
Free Cash Flow Margin	15.77%	15.13%	12.61%	17.87%	20.07%	16.53%
EBITDA	9,746	8,871	8,688	10,720	10,635	7,562
EBITDA Margin	22.22%	21.14%	21.66%	24.55%	24.68%	21.85%
D&A For EBITDA	1,725	1,878	1,966	2,013	2,047	2,132
EBIT	8,021	6,993	6,722	8,707	8,588	5,430
EBIT Margin	18.29%	16.66%	16.75%	19.94%	19.93%	15.69%
Effective Tax Rate	-71.74%	-91.1%	14.12%	16.53%	13.88%	9.48%

Abbott Laboratories (ABT) Price

ABT Stock Price Chart

ABT Income

Follow-Up Questions